Regression of cardiac amyloid deposits with novel therapeutics: reaching new frontiers in cardiac ATTR amyloidosis

Back

ESC Premium Access

Regression of cardiac amyloid deposits with novel therapeutics: reaching new frontiers in cardiac ATTR amyloidosis

Session: Advances in the Diagnosis and Treatment of Cardiac Amyloidosis

Topic: Infiltrative Myocardial Disease

Speaker: Doctor L. Chacko (London, GB)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Liza Chacko

University College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Prognostic impact of suspected cardiac amyloidosis in aortic stenosis patients referred for transcatheter aortic valve implantation

Speaker: Doctor V. Ferreira (Lisbon, PT)

Access

Abstract

Slides

Hereditary transthyretin amyloidosis: predictors of conduction disease

Speaker: Doctor A. Dias De Frias (Porto, PT)

Access

Abstract

Slides

High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

Speaker: Doctor V. Castiglione (Pisa, IT)

Access

Abstract

Slides

Regional cardiac uptake of 99-Tc-DPD is a novel powerful and independent prognostic marker in cardiac ATTR wild type amyloidosis.

Speaker: Doctor P. Milani (Pavia, IT)

Access

Abstract

Slides

Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy

Speaker: Doctor C. Rapezzi (Ferrara, IT)

Access

Abstract

Slides

Access the full session

Advances in the Diagnosis and Treatment of Cardiac Amyloidosis

Speakers: Doctor L. Chacko, Doctor V. Ferreira, Doctor A. Dias De Frias, Doctor V. Castiglione, Doctor P. Milani...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources